These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 26089013)
21. Association between high-sensitivity cardiac troponin T and N-terminal pro-brain natriuretic peptide in a community based population. Xu R; Ye P; Luo L; Sheng L; Wu H; Xiao W; Zheng J; Wang F; Xiao T Chin Med J (Engl); 2014; 127(4):638-44. PubMed ID: 24534215 [TBL] [Abstract][Full Text] [Related]
22. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications. Pareek M Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244 [TBL] [Abstract][Full Text] [Related]
23. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure. Passino C; Severino S; Poletti R; Piepoli MF; Mammini C; Clerico A; Gabutti A; Nassi G; Emdin M J Am Coll Cardiol; 2006 May; 47(9):1835-9. PubMed ID: 16682309 [TBL] [Abstract][Full Text] [Related]
24. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery. Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043 [TBL] [Abstract][Full Text] [Related]
25. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study). Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111 [TBL] [Abstract][Full Text] [Related]
26. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment. Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Wallentin L; Lindholm D; Siegbahn A; Wernroth L; Becker RC; Cannon CP; Cornel JH; Himmelmann A; Giannitsis E; Harrington RA; Held C; Husted S; Katus HA; Mahaffey KW; Steg PG; Storey RF; James SK; Circulation; 2014 Jan; 129(3):293-303. PubMed ID: 24170388 [TBL] [Abstract][Full Text] [Related]
28. High-sensitive troponin-T in adult congenital heart disease. Eindhoven JA; Roos-Hesselink JW; van den Bosch AE; Kardys I; Cheng JM; Veenis JF; Cuypers JAAE; Witsenburg M; van Schaik RHN; Boersma E Int J Cardiol; 2015 Apr; 184():405-411. PubMed ID: 25746495 [TBL] [Abstract][Full Text] [Related]
29. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure. Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451 [TBL] [Abstract][Full Text] [Related]
30. Admission N-terminal pro-brain natriuretic peptide and its interaction with admission troponin T and ST segment resolution for early risk stratification in ST elevation myocardial infarction. Björklund E; Jernberg T; Johanson P; Venge P; Dellborg M; Wallentin L; Lindahl B; Heart; 2006 Jun; 92(6):735-40. PubMed ID: 16251228 [TBL] [Abstract][Full Text] [Related]
31. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study. Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877 [TBL] [Abstract][Full Text] [Related]
32. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF). McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362 [TBL] [Abstract][Full Text] [Related]
33. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related]
34. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure]. Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987 [TBL] [Abstract][Full Text] [Related]
35. The predictive value of NT-proBNP and hs-TnT for risk of death in cardiac surgical patients. Brynildsen J; Petäjä L; Pettilä V; Nygård S; Vaara ST; Linko R; Okkonen M; Hagve TA; Soininen L; Suojaranta-Ylinen R; Lyngbakken MN; Omland T; Røsjø H Clin Biochem; 2018 Mar; 53():65-71. PubMed ID: 29371002 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related]
37. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
38. NT-proBNP in patients with out-of-hospital cardiac arrest: Results from the FINNRESUSCI Study. Myhre PL; Tiainen M; Pettilä V; Vaahersalo J; Hagve TA; Kurola J; Varpula T; Omland T; Røsjø H; Resuscitation; 2016 Jul; 104():12-8. PubMed ID: 27109503 [TBL] [Abstract][Full Text] [Related]
39. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study). Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078 [No Abstract] [Full Text] [Related]
40. Independent elevations of N-terminal pro-brain natriuretic peptide and cardiac troponins in endurance athletes after prolonged strenuous exercise. Scharhag J; Herrmann M; Urhausen A; Haschke M; Herrmann W; Kindermann W Am Heart J; 2005 Dec; 150(6):1128-34. PubMed ID: 16338248 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]